{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:23:35Z","timestamp":1779344615160,"version":"3.51.4"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.brainres.2025.150032","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:17:15Z","timestamp":1762481835000},"page":"150032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"1870","author":[{"given":"Kirsten Johanna","family":"Hendricus Maes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1405-5232","authenticated-orcid":false,"given":"Jacco Jan","family":"Bried\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","article-title":"The gold complex auranofin: new perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discov. Oncol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2012.02.006","article-title":"Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures","volume":"46","author":"Abraham","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056586","article-title":"Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response","volume":"8","author":"Adzemovic","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/21553769.2018.1491427","article-title":"Challenges associated with ceftriaxone resistance in Salmonella","volume":"11","author":"Al Kraiem","year":"2018","journal-title":"Front. Life Sci."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0025","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/hmg\/ddad209","article-title":"ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation","volume":"33","author":"Allison","year":"2024","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0030","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ana.25251","article-title":"Integrated MRI and [11C]-PBR28 PET imaging in amyotrophic lateral sclerosis","volume":"83","author":"Alshikho","year":"2018","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/adt.2016.728","article-title":"Neuroprotective properties of a macrolide antibiotic in a mouse model of middle cerebral artery occlusion: characterization of the immunomodulatory effects and validation of the efficacy of intravenous administration","volume":"14","author":"Amantea","year":"2016","journal-title":"Assay Drug Dev. Technol."},{"issue":"7\u20138","key":"10.1016\/j.brainres.2025.150032_b0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/21678421.2020.1771734","article-title":"Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis","volume":"21","author":"Andrews","year":"2020","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"key":"10.1016\/j.brainres.2025.150032_b0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jgar.2020.01.022","article-title":"Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: back to the future","volume":"22","author":"Asadi","year":"2020","journal-title":"J. Global Antimicrobial Resistance"},{"key":"10.1016\/j.brainres.2025.150032_b0050","article-title":"Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial","volume":"30","author":"Babu","year":"2021","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.brainres.2025.150032_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7840724","article-title":"The use of IL-1 receptor antagonist (anakinra) in idiopathic recurrent pericarditis: a narrative review","volume":"2016","author":"Baskar","year":"2016","journal-title":"Cardiol. Res. Pract."},{"issue":"40","key":"10.1016\/j.brainres.2025.150032_b0060","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa124","article-title":"Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses","volume":"2","author":"B\u00e9land","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.brainres.2025.150032_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","article-title":"Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease","volume":"204","author":"Bennett","year":"2019","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0080","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mus.25733","article-title":"Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability","volume":"56","author":"Berry","year":"2017","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0085","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3892\/mmr.2014.2480","article-title":"Rifampicin improves neuronal apoptosis in LPS-stimulated co-cultured BV2 cells through inhibition of the TLR-4 pathway","volume":"10","author":"Bi","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.brainres.2025.150032_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2011.04.019","article-title":"Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation","volume":"1395","author":"Bi","year":"2011","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.brainres.2025.150032_b0095","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/glia.20830","article-title":"Sodium channel activity modulates multiple functions in microglia","volume":"57","author":"Black","year":"2009","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b0100","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40265-023-01904-6","article-title":"Tofersen: first approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.brainres.2025.150032_b0105","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/ijms21072395","article-title":"Abnormal upregulation of GPR17 receptor contributes to oligodendrocyte dysfunction in SOD1 G93A mice","volume":"21","author":"Bonfanti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039216","article-title":"Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis","volume":"7","author":"Brettschneider","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.brainres.2025.150032_b0115","first-page":"CT171","volume":"88","author":"Brooks","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.brainres.2025.150032_b0120","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1172\/JCI62636","article-title":"Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS","volume":"122","author":"Butovsky","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.brainres.2025.150032_b0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00001813-200009000-00002","article-title":"Exemestane in advanced breast cancer","volume":"11","author":"Buzdar","year":"2000","journal-title":"Anticancer Drugs"},{"issue":"7","key":"10.1016\/j.brainres.2025.150032_b0130","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1310\/hpj4807-580","article-title":"Alogliptin","volume":"48","author":"Cada","year":"2013","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.brainres.2025.150032_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223096","article-title":"Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis","volume":"14","author":"Calafatti","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/WCO.0000000000001279","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications","volume":"37","author":"Calma","year":"2024","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1078155216634178","article-title":"Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma","volume":"23","author":"Campbell","year":"2017","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"10","key":"10.1016\/j.brainres.2025.150032_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102092","article-title":"Neuromuscular junction dismantling in amyotrophic lateral sclerosis","volume":"18","author":"Cappello","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/104990910502200112","article-title":"Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study","volume":"22","author":"Carter","year":"2005","journal-title":"Am. J. Hospice Palliative Med."},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/antiox11020195","article-title":"Effects of the edaravone, a drug approved for the treatment of amyotrophic lateral sclerosis, on mitochondrial function and neuroprotection","volume":"11","author":"Cha","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.brainres.2025.150032_b0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euroneuro.2020.11.007","article-title":"Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: a promising drug repurposing for bipolar disorder treatment?","volume":"42","author":"Chaves Filho","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2025.150032_b0170","doi-asserted-by":"crossref","first-page":"40528","DOI":"10.1038\/srep40528","article-title":"Disease-modifying effect of intravenous immunoglobulin in an experimental model of epilepsy","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b0175","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41593-020-00718-z","article-title":"Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival","volume":"23","author":"Chiot","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/ph14010029","article-title":"Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis","volume":"14","author":"Cho","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.brainres.2025.150032_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1283711","article-title":"Limitations of PLX3397 as a microglial investigational tool: peripheral and off-target effects dictate the response to inflammation","volume":"14","author":"Claeys","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.brainres.2025.150032_b0190","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1093\/brain\/awaa309","article-title":"The microglial component of amyotrophic lateral sclerosis","volume":"143","author":"Clarke","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2025.150032_b0195","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbi.2018.07.002","article-title":"Ca2+-activated K+ channels modulate microglia affecting motor neuron survival in hSOD1G93A mice","volume":"73","author":"Cocozza","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.brainres.2025.150032_b0200","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2016.06.006","article-title":"Astrocytes: key regulators of neuroinflammation","volume":"37","author":"Colombo","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.brainres.2025.150032_b0205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.brainres.2025.150032_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052941","article-title":"Molecular imaging of microglial activation in amyotrophic lateral sclerosis","volume":"7","author":"Corcia","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0215","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.annemergmed.2023.05.024","article-title":"Managing and preventing migraine in the emergency department: a review","volume":"82","author":"Cortel-LeBlanc","year":"2023","journal-title":"Ann. Emerg. Med."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.20903","article-title":"Trial of celecoxib in amyotrophic lateral sclerosis","volume":"60","author":"Cudkowicz","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2025.150032_b0225","doi-asserted-by":"crossref","unstructured":"Cudkowicz, M. E., Titus, S., Kearney, M., Yu, H., Sherman, A., Schoenfeld, D., Hayden, D., Shui, A., Brooks, B., Conwit, R., Felsenstein, D., Greenblatt, D. J., Keroack, M., Kissel, J. T., Miller, R., Rosenfeld, J., Rothstein, J. D., Simpson, E., Tolkoff-Rubin, N., \u2026 Ceftriaxone Study Investigators. (2014). Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: A multi-stage, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology, 13(11), 1083\u20131091. https:\/\/doi.org\/10.1016\/S1474-4422(14)70222-4.","DOI":"10.1016\/S1474-4422(14)70222-4"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0230","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1038\/s41598-021-95059-7","article-title":"Inhibition of CSF1R, a receptor involved in microglia viability, alters behavioral and molecular changes induced by cocaine","volume":"11","author":"da Silva","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12974-015-0435-0","article-title":"Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model","volume":"12","author":"Dahlke","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.brainres.2025.150032_b0240","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archneur.1994.00540210031010","article-title":"Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy","volume":"51","author":"Dalakas","year":"1994","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.brainres.2025.150032_b0245","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/glia.22992","article-title":"KCa3.1\u2014A microglial target ready for drug repurposing?","volume":"64","author":"Dale","year":"2016","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.brainres.2025.150032_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29686","article-title":"Monocytes and macrophages: origin, homing, differentiation, and functionality during inflammation","volume":"10","author":"Dash","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.brainres.2025.150032_b0255","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neubiorev.2021.06.027","article-title":"Interplay between immunity and amyotrophic lateral sclerosis: clinical impact","volume":"127","author":"De Marchi","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.brainres.2025.150032_b0260","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/genes14081658","article-title":"Neuroinflammatory pathways in the ALS-FTD continuum: a focus on genetic variants","volume":"14","author":"De Marchi","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.brainres.2025.150032_b0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1742-2094-9-117","article-title":"Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer\u2019s disease","volume":"9","author":"Dhawan","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0270","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1007\/s12035-024-04664-w","article-title":"Pioglitazone modulates microglia M1\/M2 polarization through PPAR-\u03b3 pathway and exerts neuroprotective effects in experimental subarachnoid hemorrhage","volume":"62","author":"Ding","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0275","doi-asserted-by":"crossref","first-page":"e829","DOI":"10.1212\/NXI.0000000000000829","article-title":"Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis","volume":"7","author":"Dols-Icardo","year":"2020","journal-title":"Neurol. (r) Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.brainres.2025.150032_b0280","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2147\/DMSO.S375559","article-title":"The relationship between the blood-brain-barrier and the central effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors","volume":"15","author":"Dong","year":"2022","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"key":"10.1016\/j.brainres.2025.150032_b0285","doi-asserted-by":"crossref","unstructured":"Dupuis, L., Dengler, R., Heneka, M. T., Meyer, T., Zierz, S., Kassubek, J., Fischer, W., Steiner, F., Lindauer, E., Otto, M., Dreyhaupt, J., Grehl, T., Hermann, A., Winkler, A. S., Bogdahn, U., Benecke, R., Schrank, B., Wessig, C., Grosskreutz, J., \u2026 The GERP ALS Study Group. (2012). A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS ONE, 7(6), e37885. https:\/\/doi.org\/10.1371\/journal.pone.0037885.","DOI":"10.1371\/journal.pone.0037885"},{"key":"10.1016\/j.brainres.2025.150032_b0290","unstructured":"EMA. (2024, June 28). Masitinib AB Science | European Medicines Agency (EMA). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/masitinib-ab-science."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0295","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-019-1613-2","article-title":"Quercetin prevents necroptosis of oligodendrocytes by inhibiting macrophages\/microglia polarization to M1 phenotype after spinal cord injury in rats","volume":"16","author":"Fan","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2025.150032_b0300","doi-asserted-by":"crossref","unstructured":"Fan, L.-W., Kaizaki, A., Tien, L.-T., Pang, Y., Tanaka, S., Numazawa, S., Bhatt, A. J., Cai, Z. (2013). Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. Neuroscience, 240, 27\u201338. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.02.041.","DOI":"10.1016\/j.neuroscience.2013.02.041"},{"issue":"10360","key":"10.1016\/j.brainres.2025.150032_b0305","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.brainres.2025.150032_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.773288","article-title":"Tofacitinib suppresses natural killer cells in vitro and in vivo: implications for amyotrophic lateral sclerosis","volume":"13","author":"Figueroa-Romero","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2025.150032_b0315","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neures.2017.05.005","article-title":"Rebamipide reduces amyloid-\u03b2 1\u201342 (A\u03b242) production and ameliorates A\u03b243-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells","volume":"124","author":"Fukui","year":"2017","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0320","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0325","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41467-020-15644-8","article-title":"Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis","volume":"11","author":"Garofalo","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0330","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00253-021-11094-4","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story","volume":"105","author":"Gasmi","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"JUL","key":"10.1016\/j.brainres.2025.150032_b0335","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fnagi.2017.00242","article-title":"The dual role of microglia in ALS: mechanisms and therapeutic approaches","volume":"9","author":"Geloso","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036000","article-title":"Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Gerber","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0345","article-title":"Treatment of fatigue in amyotrophic lateral sclerosis\/motor neuron disease","volume":"2018","author":"Gibbons","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.brainres.2025.150032_b0350","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1212\/01.WNL.0000125321.92112.7E","article-title":"Placebo-controlled phase I\/II studies of minocycline in amyotrophic lateral sclerosis","volume":"62","author":"Gordon","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.brainres.2025.150032_b0355","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0360","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ajpath.2013.02.043","article-title":"Pazopanib inhibits the activation of PDGFR\u03b2-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells","volume":"182","author":"Gril","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2025.150032_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577284","article-title":"Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer\u2019s disease mice via the downregulation of TLR4\/Myd88\/NF-\u03baB pathway","volume":"346","author":"Guo","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2025.150032_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0375","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00018-022-04225-1","article-title":"Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges","volume":"79","author":"Han","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.brainres.2025.150032_b0380","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3390\/cells9071655","article-title":"Regorafenib regulates ad pathology, neuroinflammation, and dendritic spinogenesis in cells and a mouse model of AD","volume":"9","author":"Han","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.brainres.2025.150032_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102010","article-title":"Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy","volume":"44","author":"Han","year":"2021","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0390","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neulet.2009.08.043","article-title":"Cerebroprotective action of telmisartan by inhibition of macrophages\/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor \u03b3-dependent mechanism","volume":"464","author":"Haraguchi","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2025.150032_b0395","first-page":"287","article-title":"Chapter ten\u2014modafinil, an atypical CNS stimulant?","volume":"99","author":"Hersey","year":"2024"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0400","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12974-022-02430-0","article-title":"Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4\/NF-\u03baB signaling pathway","volume":"19","author":"Hu","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0405","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10571-020-00856-9","article-title":"FTY720 modulates microglia toward anti-inflammatory phenotype by suppressing autophagy via STAT1 pathway","volume":"41","author":"Hu","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2025.150032_b0410","doi-asserted-by":"crossref","DOI":"10.1177\/09636897241237049","article-title":"Pomalidomide improves motor behavioral deficits and protects cerebral cortex and striatum against neurodegeneration through a reduction of oxidative\/nitrosative damages and neuroinflammation after traumatic brain injury","volume":"33","author":"Huang","year":"2024","journal-title":"Cell Transplant."},{"key":"10.1016\/j.brainres.2025.150032_b0415","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemotherapy Res. Pract."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0420","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1445-5994.2009.01947.x","article-title":"Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate","volume":"39","author":"Isobe","year":"2009","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.brainres.2025.150032_b0425","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3389\/fnins.2020.00824","article-title":"Rising stars: astrocytes as a therapeutic target for ALS disease","volume":"14","author":"Izrael","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0430","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12017-025-08871-z","article-title":"A slower-progressing TDP-43 rNLS8 mouse model for ALS: implications for preclinical and mechanistic studies","volume":"27","author":"Jagaraj","year":"2025","journal-title":"NeuroMol. Med."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0435","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/WNR.0000000000000740","article-title":"Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson\u2019s disease","volume":"28","author":"Jang","year":"2017","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0440","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JAD-170429","article-title":"Pazopanib reduces phosphorylated tau levels and alters astrocytes in a mouse model of tauopathy","volume":"60","author":"Javidnia","year":"2017","journal-title":"J. Alzheimer\u2019s Disease: JAD"},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0445","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/acn3.754","article-title":"Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer\u2019s disease","volume":"6","author":"Jin","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.brainres.2025.150032_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114515","article-title":"Quercetin activates the Sestrin2\/AMPK\/SIRT1 axis to improve amyotrophic lateral sclerosis","volume":"161","author":"Jin","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0455","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jb\/mvw009","article-title":"Microglia in central nervous system repair after injury","volume":"159","author":"Jin","year":"2016","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0460","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11481-025-10194-6","article-title":"Modafinil ameliorated fibromyalgia syndrome in rats by modulating mast cells and microglia activation through dopamine\/substance P\/MRGPRX\/histamine and PI3K\/p-Akt\/NF-\u03baB signaling pathways","volume":"20","author":"Kamal","year":"2025","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0465","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s10020-023-00718-2","article-title":"Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt\/\u03b2-catenin\/NeuroD1 pathway","volume":"29","author":"Kang","year":"2023","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.brainres.2025.150032_b0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046185","article-title":"C-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis","volume":"7","author":"Katsumata","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2025.150032_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684344","article-title":"Sorafenib modulates the LPS- and A\u03b2-induced neuroinflammatory response in cells, wild-type mice, and 5xFAD mice","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0480","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","article-title":"Evidence for the use of intravenous immunoglobulins\u2014a review of the literature","volume":"38","author":"Kivity","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"173","key":"10.1016\/j.brainres.2025.150032_b0485","article-title":"Compassionate use of the ROCK inhibitor fasudil in three patients with amyotrophic lateral sclerosis","volume":"11","author":"Koch","year":"2020","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b0490","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1474-4422(24)00373-9","article-title":"Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"23","author":"Koch","year":"2024","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2015.08.1525","article-title":"Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis","volume":"358","author":"Koch","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0500","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/brainsci13060858","article-title":"Phenytoin decreases pain-like behaviors and improves opioid analgesia in a rat model of neuropathic pain","volume":"13","author":"Kocot-K\u0119pska","year":"2023","journal-title":"Brain Sci."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0505","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ana.26600","article-title":"Protective effects of lovastatin in a population-based ALS study and mouse model","volume":"93","author":"Kreple","year":"2023","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b0510","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1007\/s12031-022-02071-1","article-title":"Integrative analysis of motor neuron and microglial transcriptomes from SOD1G93A mice models uncover potential drug treatments for ALS","volume":"72","author":"Kubat Oktem","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"16","key":"10.1016\/j.brainres.2025.150032_b0515","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.3390\/ijms22168429","article-title":"Immunometabolic modulatory role of naltrexone in BV-2 microglia cells","volume":"22","author":"Ku\u010di\u0107","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.150032_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112896","article-title":"Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2\/TLR4 antagonist (+)-naltrexone","volume":"396","author":"Kwilasz","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0525","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s11481-017-9746-5","article-title":"Involvement of c-Abl Kinase in microglial activation of NLRP3 inflammasome and impairment in autolysosomal system","volume":"12","author":"Lawana","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"7","key":"10.1016\/j.brainres.2025.150032_b0530","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/glia.22496","article-title":"Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model","volume":"61","author":"Lazzarini","year":"2013","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115176","article-title":"The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice","volume":"44","author":"Le","year":"2025","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0540","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s12035-017-0550-2","article-title":"Activation of glucagon-like peptide-1 receptor promotes neuroprotection in experimental autoimmune encephalomyelitis by reducing neuroinflammatory responses","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0545","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13332","article-title":"Ibrutinib modulates A\u03b2\/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer\u2019s disease","volume":"20","author":"Lee","year":"2021","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0550","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12975-023-01152-6","article-title":"Repurposing the KCa3.1 blocker senicapoc for ischemic stroke","volume":"15","author":"Lee","year":"2024","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.brainres.2025.150032_b0555","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.612981","article-title":"Anti-inflammatory effects of dimethyl fumarate in microglia via an autophagy dependent pathway","volume":"12","author":"Lee","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0560","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13041-023-01047-5","article-title":"Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice","volume":"16","author":"Li","year":"2023","journal-title":"Mol. Brain"},{"key":"10.1016\/j.brainres.2025.150032_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112473","article-title":"Microglial repopulation induced by PLX3397 protects against ischemic brain injury by suppressing neuroinflammation in aged mice","volume":"138","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.brainres.2025.150032_b0570","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2015.06.008","article-title":"Rifampicin attenuates rotenone-induced inflammation via suppressing NLRP3 inflammasome activation in microglia","volume":"1622","author":"Liang","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2025.150032_b0575","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuro.2017.09.015","article-title":"Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy","volume":"63","author":"Liang","year":"2017","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0580","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","article-title":"Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS","volume":"237","author":"Liao","year":"2012","journal-title":"Exp. Neurol."},{"issue":"7638","key":"10.1016\/j.brainres.2025.150032_b0585","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0590","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12974-025-03461-z","article-title":"Rebamipide (Mucosta\u00ae), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson\u2019s disease model","volume":"22","author":"Lim","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2025.150032_b0595","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.767041","article-title":"Neuroinflammation in amyotrophic lateral sclerosis and frontotemporal dementia and the interest of induced pluripotent stem cells to study immune cells interactions with neurons","volume":"14","author":"Liu","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2025.150032_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110683","article-title":"Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial\/macrophages activation in glial glutamate transporter-1 dependent manner in the APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"200","author":"Liu","year":"2023","journal-title":"Brain Res. Bull."},{"issue":"8","key":"10.1016\/j.brainres.2025.150032_b0605","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1089\/neu.2011.2114","article-title":"Aquaporin-4 reduces post-traumatic seizure susceptibility by promoting astrocytic glial scar formation in mice","volume":"38","author":"Lu","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.brainres.2025.150032_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114464","article-title":"Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1\/STAT6 pathways","volume":"186","author":"Lu","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2025.150032_b0615","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4 +T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"9","key":"10.1016\/j.brainres.2025.150032_b0620","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/00207454.2013.856009","article-title":"Ceftriaxone pretreatment protects rats against cerebral ischemic injury by attenuating microglial activation-induced IL-1\u03b2 expression","volume":"124","author":"Lujia","year":"2014","journal-title":"Int. J. Neurosci."},{"issue":"15","key":"10.1016\/j.brainres.2025.150032_b0625","article-title":"Cancer drug repurposing for treating amyotrophic lateral sclerosis (ALS) (S5.004)","volume":"92","author":"Lukas","year":"2019","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b0630","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/brainsci11111411","article-title":"LINCS dataset-based repositioning of dutasteride as an anti-neuroinflammation agent","volume":"11","author":"Luo","year":"2021","journal-title":"Brain Sci."},{"issue":"15","key":"10.1016\/j.brainres.2025.150032_b0635","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.7150\/ijbs.84564","article-title":"Tofacitinib promotes functional recovery after spinal cord injury by regulating microglial polarization via JAK\/STAT signaling pathway","volume":"19","author":"Ma","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.150032_b0640","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2014.08.615","article-title":"Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst","volume":"276","author":"Madeira","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.brainres.2025.150032_b0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139684","article-title":"Interleukin-1 antagonist Anakinra in amyotrophic lateral sclerosis\u2014a pilot study","volume":"10","author":"Maier","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0650","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1038\/s41467-023-40734-8","article-title":"Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis","volume":"14","author":"Mandrioli","year":"2023","journal-title":"Nat. Commun."},{"issue":"6435","key":"10.1016\/j.brainres.2025.150032_b0655","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.aav9776","article-title":"Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis","volume":"364","author":"Maniatis","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.150032_b0660","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.taap.2018.09.012","article-title":"Montelukast attenuates rotenone-induced microglial activation\/p38 MAPK expression in rats: possible role of its antioxidant, anti-inflammatory and antiapoptotic effects","volume":"358","author":"Mansour","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.brainres.2025.150032_b0665","doi-asserted-by":"crossref","first-page":"25663","DOI":"10.1038\/srep25663","article-title":"CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves","volume":"6","author":"Mart\u00ednez-Muriana","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0670","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/ph18040497","article-title":"Enhanced acute muscle activation in ALS patients following liposomal curcumin, resveratrol, and dutasteride administration","volume":"18","author":"Mart\u00edn-Ruiz","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0675","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5455\/aim.2012.20.72-84","article-title":"On-line biomedical databases-the best source for quick search of the scientific information in the biomedicine","volume":"20","author":"Masic","year":"2012","journal-title":"Acta Informatica Medica"},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0680","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b0685","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02444000","article-title":"Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis","volume":"243","author":"Meucci","year":"1996","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0690","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4103\/bc.bc_38_24","article-title":"Effects and mechanisms of long-acting glucagon-like peptide-1 receptor agonist semaglutide on microglia phenotypic transformation and neuroinflammation after cerebral ischemia\/reperfusion in rats","volume":"10","author":"Mi","year":"2024","journal-title":"Brain Circ."},{"issue":"12","key":"10.1016\/j.brainres.2025.150032_b0695","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2025.150032_b0700","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1277399","article-title":"Immunology of amyotrophic lateral sclerosis \u2013 role of the innate and adaptive immunity","volume":"17","author":"Mimic","year":"2023","journal-title":"Front. Neurosci."},{"issue":"20","key":"10.1016\/j.brainres.2025.150032_b0705","doi-asserted-by":"crossref","first-page":"10951","DOI":"10.3390\/ijms252010951","article-title":"Microglia signatures: a cause or consequence of microglia-related brain disorders?","volume":"25","author":"Mirarchi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0710","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2003.09.009","article-title":"Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia","volume":"46","author":"Mizuno","year":"2004","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0715","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1007\/s12035-021-02285-1","article-title":"Modulators of neuroinflammation have a beneficial effect in a Lafora disease mouse model","volume":"58","author":"Moll\u00e1","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2025.150032_b0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562864211030365","article-title":"Long-term survival analysis of masitinib in amyotrophic lateral sclerosis","volume":"14","author":"Mora","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.150032_b0725","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21678421.2019.1632346","article-title":"Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial","volume":"21","author":"Mora","year":"2020","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b0730","article-title":"NK cells associate with ALS in a sex- and age-dependent manner","volume":"6","author":"Murdock","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.brainres.2025.150032_b0735","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.70127","article-title":"In vitro modeling of natural killer cell cytotoxicity to inform personalized ALS therapeutics","author":"Murdock","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.brainres.2025.150032_b0740","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12974-018-1308-0","article-title":"Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice","volume":"15","author":"Nam","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0745","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-018-0271-7","article-title":"Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice","volume":"13","author":"Nardo","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"18","key":"10.1016\/j.brainres.2025.150032_b0750","doi-asserted-by":"crossref","first-page":"10590","DOI":"10.3390\/ijms231810590","article-title":"Sonidegib suppresses production of inflammatory mediators and cell migration in BV2 microglial cells and mice treated with lipopolysaccharide via JNK and NF-\u03baB inhibition","volume":"23","author":"Nguyen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0755","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4062\/biomolther.2022.076","article-title":"Efonidipine inhibits JNK and NF-\u03baB pathway to attenuate inflammation and cell migration induced by lipopolysaccharide in microglial cells","volume":"30","author":"Nguyen","year":"2022","journal-title":"Biomol. Ther."},{"issue":"16","key":"10.1016\/j.brainres.2025.150032_b0760","doi-asserted-by":"crossref","first-page":"9061","DOI":"10.3390\/ijms22169061","article-title":"Suppression of LPS-induced inflammation and cell migration by azelastine through inhibition of JNK\/NF-\u03baB pathway in BV2 microglial cells","volume":"22","author":"Nguyen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0765","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/WCO.0000000000001294","article-title":"The genetics of amyotrophic lateral sclerosis","volume":"37","author":"Nijs","year":"2024","journal-title":"Curr. Opin. Neurol."},{"issue":"10","key":"10.1016\/j.brainres.2025.150032_b0770","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/ejn.13227","article-title":"Comparative morphometric analysis of microglia in the spinal cord of SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis","volume":"43","author":"Ohgomori","year":"2016","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0775","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/nmt-2021-0042","article-title":"MN-166 (ibudilast) in amyotrophic lateral sclerosis in a phase IIb\/III study: COMBAT-ALS study design","volume":"11","author":"Oskarsson","year":"2021","journal-title":"Neurodegen. Dis. Manage."},{"key":"10.1016\/j.brainres.2025.150032_b0780","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.brainres.2025.150032_b0785","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"22","key":"10.1016\/j.brainres.2025.150032_b0790","doi-asserted-by":"crossref","first-page":"14196","DOI":"10.3390\/ijms232214196","article-title":"3K3A-activated protein C prevents microglia activation, inhibits NLRP3 inflammasome and limits ocular inflammation","volume":"23","author":"Palevski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0795","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s13311-022-01182-2","article-title":"Repurposing pomalidomide as a neuroprotective drug: efficacy in an alpha-synuclein-based model of Parkinson\u2019s disease","volume":"19","author":"Palmas","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmicom.2025.105059","article-title":"Tetracyclines, the old and the new: a narrative review","volume":"2","author":"Pearson","year":"2025","journal-title":"CMI Commun."},{"issue":"3\u20134","key":"10.1016\/j.brainres.2025.150032_b0805","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/21678421.2019.1682613","article-title":"Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs","volume":"21","author":"Pfeiffer","year":"2020","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0810","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40478-016-0340-5","article-title":"From animal models to human disease: a genetic approach for personalized medicine in ALS","volume":"4","author":"Picher-Martel","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.brainres.2025.150032_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104665","article-title":"Propranolol diminished severity of rat EAE by enhancing immunoregulatory\/protective properties of spinal cord microglia","volume":"134","author":"Pilipovi\u0107","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0820","article-title":"Exploring antioxidant strategies in the pathogenesis of ALS","volume":"19","author":"Pinilla-Gonz\u00e1lez","year":"2024","journal-title":"Open Life Sci."},{"key":"10.1016\/j.brainres.2025.150032_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106347","article-title":"Discovery of novel targets in a complex regional pain syndrome mouse model by transcriptomics: TNF and JAK-STAT pathways","volume":"182","author":"Poh\u00f3czky","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0830","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s13311-016-0462-2","article-title":"Fingolimod: a disease-modifier drug in a mouse model of amyotrophic lateral sclerosis","volume":"13","author":"Potenza","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brainres.2025.150032_b0835","unstructured":"Qalsody (n.d.). European Medicines Agency. Retrieved December 4, 2024, from https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/qalsody."},{"key":"10.1016\/j.brainres.2025.150032_b0840","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420974900","article-title":"Candesartan modulates microglia activation and polarization via NF-\u03baB signaling pathway","volume":"34","author":"Qie","year":"2020","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"12","key":"10.1016\/j.brainres.2025.150032_b0845","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1161\/STROKEAHA.117.018505","article-title":"Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway","volume":"48","author":"Qin","year":"2017","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0850","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12974-022-02421-1","article-title":"ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression","volume":"19","author":"Quek","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0855","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.21245","article-title":"Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study","volume":"39","author":"Rabkin","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.brainres.2025.150032_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116084","article-title":"Redox aspects of cytotoxicity and anti-neuroinflammatory profile of chloroquine and hydroxychloroquine in serum-starved BV-2 microglia","volume":"447","author":"Ra\u010dkov\u00e1","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"18","key":"10.1016\/j.brainres.2025.150032_b0865","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1111\/bph.16408","article-title":"Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity","volume":"181","author":"Raffaele","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000519874","article-title":"Azithromycin protects oligodendrocyte progenitor cells against lipopolysaccharide-activated microglia-induced damage","volume":"44","author":"Ramarao","year":"2022","journal-title":"Dev. Neurosci."},{"issue":"18","key":"10.1016\/j.brainres.2025.150032_b0875","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1021\/acschemneuro.4c00205","article-title":"Repurposing anakinra for Alzheimer\u2019s disease: the in vitro and in vivo effects of anakinra on LPS- and AC-induced neuroinflammation","volume":"15","author":"Retinasamy","year":"2024","journal-title":"ACS Chem. Nerosci."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0880","doi-asserted-by":"crossref","first-page":"13507","DOI":"10.1038\/s41598-024-63942-8","article-title":"Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures","volume":"14","author":"Rodriguez","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0885","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s13311-018-0646-z","article-title":"Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death","volume":"15","author":"Rodriguez-Perez","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brainres.2025.150032_b0890","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.566858","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative motor neuron disease with ocular involvement","volume":"14","author":"Rojas","year":"2020","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0895","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab157","article-title":"Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation","volume":"3","author":"Rolfes","year":"2021","journal-title":"Brain Commun."},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b0900","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","article-title":"Lifetime risk and heritability of amyotrophic lateral sclerosis","volume":"76","author":"Ryan","year":"2019","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0905","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12974-019-1561-x","article-title":"Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT\/STAT3 signaling","volume":"16","author":"Ryu","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2025.150032_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120132","article-title":"Novel mechanistic insights towards the repositioning of alogliptin in Parkinson\u2019s disease","volume":"287","author":"Safar","year":"2021","journal-title":"Life Sci."},{"issue":"23","key":"10.1016\/j.brainres.2025.150032_b0915","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.3390\/ijms252313082","article-title":"Neuroprotective and anti-inflammatory effects of dimethyl fumarate, monomethyl fumarate, and cannabidiol in neurons and microglia","volume":"25","author":"S\u00e1nchez-Sanz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0920","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/jpet.118.251264","article-title":"Celecoxib treatment improves neurologic deficit and reduces selective neuronal loss and glial response in rats after transient middle cerebral artery occlusion","volume":"367","author":"Santos-Galdiano","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0925","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"34","key":"10.1016\/j.brainres.2025.150032_b0930","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","article-title":"The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice","volume":"25","author":"Sch\u00fctz","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.150032_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2023.100105","article-title":"Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS\/FTD in vitro models","volume":"5","author":"Seidel","year":"2023","journal-title":"Curr. Res. Neurobiol."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0940","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00280-020-04071-7","article-title":"Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinib","volume":"85","author":"Shankarappa","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.brainres.2025.150032_b0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105969","article-title":"The histone deacetylase inhibitor belinostat ameliorates experimental autoimmune encephalomyelitis in mice by inhibiting TLR2\/MyD88 and HDAC3\/ NF-\u03baB p65-mediated neuroinflammation","volume":"176","author":"Shen","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.brainres.2025.150032_b0950","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1789946","article-title":"Use of off-label drugs and nutrition supplements among patients with amyotrophic lateral sclerosis in Norway","volume":"2022","author":"Skulstad Johanson","year":"2022","journal-title":"Neurol. Res. Int."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b0955","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10715762.2017.1353688","article-title":"Potential repositioning of exemestane as a neuroprotective agent for Parkinson\u2019s disease","volume":"51","author":"Son","year":"2017","journal-title":"Free Radic. Res."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b0960","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.3892\/mmr.2015.4407","article-title":"Rapamycin protects neurons from brain contusion-induced inflammatory reaction via modulation of microglial activation","volume":"12","author":"Song","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.brainres.2025.150032_b0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2025.102535","article-title":"Telmisartan is neuroprotective in a hiPSC-derived spinal microtissue model for C9orf72 ALS via inhibition of neuroinflammation","volume":"20","author":"Sonustun","year":"2025","journal-title":"Stem Cell Rep."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b0970","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/brain\/aww016","article-title":"Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology","volume":"139","author":"Spangenberg","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b0975","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41593-018-0083-7","article-title":"Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy","volume":"21","author":"Spiller","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.brainres.2025.150032_b0980","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.3390\/ijms26083854","article-title":"Neuroinflammation and amyotrophic lateral sclerosis: recent advances in anti-inflammatory cytokines as therapeutic strategies","volume":"26","author":"Stacchiotti","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.150032_b0985","doi-asserted-by":"crossref","unstructured":"Stommel, E. W., Cohen, J. A., Fadul, C. E., Cogbill, C. H., Graber, D. J., Kingman, L., Mackenzie, T., Smith, J. Y. C., Harris, B. T. (2009). Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial. Amyotrophic Lateral Sclerosis\u00a0: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 10(0), 10.3109\/17482960802709416. https:\/\/doi.org\/10.3109\/17482960802709416.","DOI":"10.1080\/17482960802709416"},{"key":"10.1016\/j.brainres.2025.150032_b0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115186","article-title":"Partial microglial depletion through inhibition of colony-stimulating factor 1 receptor improves synaptic plasticity and cognitive performance in aged mice","volume":"387","author":"Strackeljan","year":"2025","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b0995","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12974-019-1632-z","article-title":"Stress-induced microglial activation occurs through \u03b2-adrenergic receptor: noradrenaline as a key neurotransmitter in microglial activation","volume":"16","author":"Sugama","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b1000","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41401-022-01030-1","article-title":"Pazopanib alleviates neuroinflammation and protects dopaminergic neurons in LPS-stimulated mouse model by inhibiting MEK4-JNK-AP-1 pathway","volume":"44","author":"Sun","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.brainres.2025.150032_b1005","doi-asserted-by":"crossref","unstructured":"Tan, Z., Yang, G., Qiu, J., Yan, W., Liu, Y., Ma, Z., Li, J., Liu, J., Shan, N. (2021). Quercetin alleviates demyelination to mitigate neuropsychiatric symptoms through promoting microglia M2 polarization in mice with vascular dementi. https:\/\/doi.org\/10.21203\/rs.3.rs-1030799\/v1.","DOI":"10.21203\/rs.3.rs-1030799\/v1"},{"key":"10.1016\/j.brainres.2025.150032_b1010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.737065","article-title":"Dimethyl fumarate alleviates NLRP3 inflammasome activation in microglia and sickness behavior in LPS-challenged mice","volume":"12","author":"Tastan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2025.150032_b1015","article-title":"Dihydroergotamine for migraine: evidence for multiple modes of action: the single molecule \u2018combination\u2019 product\u2014a narrative review","volume":"7","author":"Tepper","year":"2024","journal-title":"Cephalalgia Rep."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b1020","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/brainsci10060348","article-title":"Comprehensive analysis of the immune and stromal compartments of the CNS in EAE mice reveal pathways by which chloroquine suppresses neuroinflammation","volume":"10","author":"Thome","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.brainres.2025.150032_b1025","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.736786","article-title":"Neuroprotective effects of ceftriaxone involve the reduction of A\u03b2 burden and neuroinflammatory response in a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Tikhonova","year":"2021","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b1030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/glia.22601","article-title":"Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis","volume":"62","author":"T\u00f6nges","year":"2014","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b1035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cns.12802","article-title":"Candesartan ameliorates brain inflammation associated with Alzheimer\u2019s disease","volume":"24","author":"Torika","year":"2018","journal-title":"CNS Neurosci. Therapeutics"},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b1040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155823","article-title":"Telmisartan modulates glial activation: in vitro and in vivo studies","volume":"11","author":"Torika","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b1045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-016-0620-9","article-title":"Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis","volume":"13","author":"Trias","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b1050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol. Disease"},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b1055","doi-asserted-by":"crossref","DOI":"10.3390\/cells13050452","article-title":"Unraveling the heterogeneity of ALS\u2014a call to redefine patient stratification for better outcomes in clinical trials","volume":"13","author":"Tzeplaeff","year":"2024","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b1060","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/cells12111523","article-title":"Current state and future directions in the therapy of ALS","volume":"12","author":"Tzeplaeff","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b1065","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/aww042","article-title":"Rifampicin is a candidate preventive medicine against amyloid-\u03b2 and tau oligomers","volume":"139","author":"Umeda","year":"2016","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b1070","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/s41467-023-41603-0","article-title":"C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9","volume":"14","author":"Vahsen","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b1075","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3390\/ijms20112818","article-title":"Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques","volume":"20","author":"van den Bos","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b1080","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","article-title":"neuromuscular junction dysfunction in amyotrophic lateral sclerosis","volume":"59","author":"Verma","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b1085","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/cells12050736","article-title":"Current state and future directions in the diagnosis of amyotrophic lateral sclerosis","volume":"12","author":"Vidovic","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.brainres.2025.150032_b1090","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/acn3.51446","article-title":"Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study","volume":"8","author":"Vucic","year":"2021","journal-title":"Ann. Clin. Trans. Neurol."},{"key":"10.1016\/j.brainres.2025.150032_b1095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-017-0856-z","article-title":"Microglial depletion alters the brain neuroimmune response to acute binge ethanol withdrawal","volume":"14","author":"Walter","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2025.150032_b1100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12974-016-0631-6","article-title":"Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat","volume":"13","author":"Wang","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2025.150032_b1105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","article-title":"Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"287","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.brainres.2025.150032_b1110","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1096\/fj.12-222992","article-title":"Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain","volume":"27","author":"Wang","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2025.150032_b1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107133","article-title":"Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer\u2019s disease","volume":"202","author":"Wang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.brainres.2025.150032_b1120","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cns.13655","article-title":"Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice","volume":"27","author":"Wang","year":"2021","journal-title":"CNS Neurosci. Therap."},{"key":"10.1016\/j.brainres.2025.150032_b1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148498","article-title":"Montelukast sodium protects against focal cerebral ischemic injury by regulating inflammatory reaction via promoting microglia polarization","volume":"1817","author":"Wang","year":"2023","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2025.150032_b1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113674","article-title":"Telmisartan ameliorates A\u03b2 oligomer-induced inflammation via PPAR\u03b3\/PTEN pathway in BV2 microglial cells","volume":"171","author":"Wang","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2025.150032_b1135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroscience.2024.11.022","article-title":"Semaglutide promotes the transition of microglia from M1 to M2 type to reduce brain inflammation in APP\/PS1\/tau mice","volume":"563","author":"Wang","year":"2024","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.brainres.2025.150032_b1140","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/acn3.326","article-title":"Dose\u2010dependent inhibition of demyelination and microglia activation by IVIG","volume":"3","author":"Winter","year":"2016","journal-title":"Ann. Clin. Trans. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b1145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","article-title":"Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis","volume":"79","author":"Witzel","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2025.150032_b1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110394","article-title":"Pre-treatment of rapamycin transformed M2 microglia alleviates traumatic cervical spinal cord injury via AIM2 signaling pathway in vitro and in vivo","volume":"121","author":"Xiao","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b1155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13195-021-00892-7","article-title":"Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer\u2019s dementia","volume":"13","author":"Xiong","year":"2021","journal-title":"Alzheimer\u2019s Res. Therapy"},{"key":"10.1016\/j.brainres.2025.150032_b1160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbi.2015.07.015","article-title":"Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKK\u03b2-dependent AMPK activation","volume":"50","author":"Xu","year":"2015","journal-title":"Brain Behav. Immunity"},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b1165","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00109-019-01761-5","article-title":"Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis","volume":"97","author":"Yadav","year":"2019","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b1170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1213\/ANE.0000000000007239","article-title":"The effect of pexidartinib on neuropathic pain via influences on microglia and neuroinflammation in mice","volume":"141","author":"Yang","year":"2025","journal-title":"Anesthesia Analgesia"},{"key":"10.1016\/j.brainres.2025.150032_b1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107748","article-title":"The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke","volume":"158","author":"Yang","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b1180","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","article-title":"T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression","volume":"13","author":"Yazdani","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.brainres.2025.150032_b1185","first-page":"1818","article-title":"Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson\u2019s disease","volume":"18","author":"Yu","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.brainres.2025.150032_b1190","doi-asserted-by":"crossref","unstructured":"Zakharova, M. V., Dyomina, A. V., Kovalenko, A. A., Zubareva, O. E., Ischenko, A. M., Zaitsev, A. V. (2024). Anakinra promotes M2 microglia activation during the latent phase of the lithium-pilocarpine model of temporal lobe epilepsy. J. Evol. Biochem. Physiol. 2024 60:2, 60(2), 672\u2013689. https:\/\/doi.org\/10.1134\/S0022093024020182.","DOI":"10.1134\/S0022093024020182"},{"issue":"12","key":"10.1016\/j.brainres.2025.150032_b1195","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/jcm8122031","article-title":"Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients","volume":"8","author":"Zeiner","year":"2019","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b1200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000351221","article-title":"Rho kinase inhibitor fasudil regulates microglia polarization and function","volume":"20","author":"Zhang","year":"2013","journal-title":"NeuroImmunoModulation"},{"issue":"8","key":"10.1016\/j.brainres.2025.150032_b1205","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1007\/s12035-023-03904-9","article-title":"Rapamycin alleviates neuronal injury and modulates microglial activation after cerebral ischemia","volume":"61","author":"Zhang","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150032_b1210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12974-016-0728-y","article-title":"The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPAR\u03b3-mediated alteration of microglial activation phenotypes","volume":"13","author":"Zhao","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.brainres.2025.150032_b1215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/glia.20919","article-title":"Extracellular mutant SOD1 induces microglial-mediated motoneuron injury","volume":"58","author":"Zhao","year":"2010","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b1220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamaneurol.2017.0357","article-title":"Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes","volume":"74","author":"Zhao","year":"2017","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150032_b1225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11481-023-10068-9","article-title":"Ibrutinib delays ALS installation and increases survival of SOD1G93A mice by modulating PI3K\/mTOR\/Akt signaling","volume":"18","author":"Zheng","year":"2023","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2025.150032_b1230","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/01616412.2024.2328481","article-title":"Dihydroergotamine protects against ischemic stroke by modulating microglial\/macrophage polarization and inhibiting inflammation in mice","volume":"46","author":"Zheng","year":"2024","journal-title":"Neurol. Res."},{"issue":"6","key":"10.1016\/j.brainres.2025.150032_b1235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/ijmm.2025.5526","article-title":"Ceftriaxone affects ferroptosis and alleviates glial cell activation in Parkinson\u2019s disease","volume":"55","author":"Zhi","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b1240","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41593-020-0619-5","article-title":"Reduced C9ORF72 function exacerbates gain-of-toxicity from ALS\/FTD-causing repeat expansion in C9orf72","volume":"23","author":"Zhu","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2025.150032_b1245","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3389\/fneur.2018.00633","article-title":"Protective effect of celecoxib on early postoperative cognitive dysfunction in geriatric patients","volume":"9","author":"Zhu","year":"2018","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.brainres.2025.150032_b1250","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s10753-024-01997-5","article-title":"Quercetin regulates microglia M1\/M2 polarization and alleviates retinal inflammation via ERK\/STAT3 pathway","volume":"47","author":"Zou","year":"2024","journal-title":"Inflammation"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325005955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325005955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:25:23Z","timestamp":1775147123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325005955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":250,"alternative-id":["S0006899325005955"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.150032","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.150032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150032"}}